Literature DB >> 2136891

Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?

Y Tomita1, H Mayumi, M Eto, K Nomoto.   

Abstract

Mechanisms of cyclophosphamide (CP)-induced tolerance were studied. When AKR/J Sea (AKR: H-2k) mice were primed i.v. with 5 x 10(7) spleen cells plus 1 x 10(7) bone marrow cells from [C57BL/6 Slc (B6; H-2b) x C3H/He Slc (C3H; H-2k)]F1 (B6C3F1) mice and treated i.p. with 200 mg/kg CP 2 days later, the survival of C3H skin was moderately prolonged, but the survival of either B6 or B6C3F1 skin was not prolonged. By this treatment, however, mixed chimerism of B6C3F1 cells in the AKR mice was not established. When C3H cells were used as the tolerogen, a minimal degree of mixed chimerism associated with profound tolerance to C3H skin was established. Similar results were observed in various donor-recipient combinations. When C3H skin was grafted in the AKR mice 12 wk after the treatment with C3H cells and CP, or B6C3F1 cells and CP, survival of the grafted C3H skin was prolonged remarkably or moderately, respectively, although mixed chimerism was not detectable at the timing of grafting in either of the groups. In this late stage of tolerance, a strong level of tolerogen-specific suppressor cell activity was observed in those tolerant AKR mice. The suppressor activity was mainly attributable to T cells. These results suggest that the role of Ts cells in order to maintain skin tolerance is important in our CP-induced tolerance system, especially in the late stage of tolerance. Moreover, the generation of the Ts cells does not necessarily require the establishment of a long term mixed chimeric state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136891

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent.

Authors:  Christopher G Kanakry; Sudipto Ganguly; Leo Luznik
Journal:  Oncoimmunology       Date:  2015-03-20       Impact factor: 8.110

Review 2.  Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?

Authors:  F Lussana; M Di Ianni; A Rambaldi
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

3.  The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.

Authors:  Joseph Rimando; Michael Slade; John F DiPersio; Peter Westervelt; Feng Gao; Chang Liu; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-26       Impact factor: 5.742

4.  Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance.

Authors:  Ichiro Shimizu; Yukihiro Tomita; Shinji Okano; Toshiro Iwai; Takashi Kajiwara; Tatsushi Onzuka; Ryuji Tominaga
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

5.  Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.

Authors:  Shuyu E; Aman Seth; Peter Vogel; Matt Sommers; Taren Ong; Asha B Pillai
Journal:  Blood       Date:  2017-03-28       Impact factor: 22.113

Review 6.  Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Authors:  Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

7.  Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.

Authors:  T Maeda; M Eto; Y Nishimura; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.

Authors:  Tatsushi Onzuka; Ichiro Shimizu; Yukihiro Tomita; Toshiro Iwai; Shinji Okano; Ryuji Tominaga
Journal:  Surg Today       Date:  2008-08-28       Impact factor: 2.549

Review 9.  Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancer.

Authors:  Christopher G Bazewicz; Saketh S Dinavahi; Todd D Schell; Gavin P Robertson
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

10.  Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.

Authors:  Christopher G Kanakry; Sudipto Ganguly; Marianna Zahurak; Javier Bolaños-Meade; Christopher Thoburn; Brandy Perkins; Ephraim J Fuchs; Richard J Jones; Allan D Hess; Leo Luznik
Journal:  Sci Transl Med       Date:  2013-11-13       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.